Company Overview and News
Matador Resources Company (MTDR - Free Report) announced that a wholly-owned subsidiary of its midstream joint venture, San Mateo Midstream, LLC, has inked a long-term agreement with a large producer in Eddy County, NM. The agreement includes the gathering and discarding of the producer’s salt water. It also comprises commitment of 65 wells, located within five miles of San Mateo’s existing salt water gathering system in Eddy County.
CVRR PAA OXY
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Chevron (CVX), Glaxo (GSK) and T-Mobile (TMUS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
COF.PRG COF.PRH COF-P UNP WLL XOM COF.WS COF.PRP QSII COF UTX COF-D COF-C COF-F CVX ED COF.PRC OXY DAL COF.PRD COF.PRF
Investors focused on the Oils-Energy space have likely heard of Occidental Petroleum (OXY - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.
Exxon Mobil Corporation (XOM - Free Report) has accelerated the development of the Liza Phase 1 after commencing development drilling offshore Guyana. Development drilling for the first of 17 wells planned for Phase 1 was initiated in May. This facilitated the start of production scheduled for 2020.The Liza prospect, operated by Exxon Mobil, is located about 120 miles (193 kilometers) offshore Guyana in the Stabroek block and spreads across 6.
HES.PRA XOM HES OXY CEO
Equinor ASA (EQNR - Free Report) along with its partners is contemplating the idea of supplying power from land to three platforms. These include Troll C and the Sleipner field center that comprises the Gudrun tie-in platform in the North Sea. Currently, these three platforms are powered by gas turbines. The company is planning to lower CO2 emissions by more than 600,000 tons annually from Troll C and the Sleipner area.
PVH WLL CVRR UTX OXY
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including United Technologies (UTX), PayPal (PYPL) and ConocoPhillips (COP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
COF.PRG COF.PRH BCS OIL COF.WS COF.PRP COP COF-D 83SF COF-C COF-F 83SK ICE COF.PRC COF.PRD 47MC COF.PRF COF-P UNP LNC.WS COF UTX ANTM PVH LNC OXY
Crude oil has been trading near $66 a barrel early on Tuesday. This is the lowest that crude oil has been at since mid-April. This comes after oil reached above $70 in late May for the first time in years. If anything, this drop might offer some stabilization, but how quickly oil will recover and then some is yet to be seen. The current crude price still pales in comparison to what it was in 2014.
COP BP XOM CVX BP BPAQF OXY PBR BP.A BP.B
The Permian formation in west Texas has been the fastest growing new source of oil in the world in the last 2 years.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), Caterpillar (CAT) and MetLife (MET). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
COF.PRG COF.PRH COF-P UNP CAT COF.WS MET COF.PRP COF COF-D BRK.A COF-C NOC COF-F 7018 PPG CME CELG COF.PRC OXY FIVE COF.PRD COF.PRF
Chicago, IL – June 11, 2018 – Today, Zacks Investment Ideas feature highlights Features: Berkshire Hathaway (BRK.B - Free Report) and J.P. Morgan Chase (JPM - Free Report) .
RYAM KBH HSC WLK ALSN LB RYAM.PRA MCHP TRTN BGSF BRK.A MU SCVL CCK OXY
Chicago, IL – June 11, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Pfizer (PFE - Free Report) , Union Pacific (UNP - Free Report) , Broadcom (AVGO - Free Report) , KeyCorp (KEY - Free Report) and Ulta Beauty (ULTA - Free Report) .
RYAM KBH HSC UNP WLK ALSN LB RYAM.PRA MCHP TRTN KEY BGSF NSC MU SCVL AVGO CCK OXY PFE
Chicago, IL – June 11, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bristol Myers (BMY - Free Report) , Merck (MRK - Free Report) , Roche (RHHBY - Free Report) , Lilly (LLY - Free Report) and AbbVie (ABBV - Free Report) .
RYAM MRK NKTR KBH HSC WLK ALSN LB RYAM.PRA MCHP TRTN BGSF MU SCVL CCK ABBV OXY ABBV
Chicago, IL – June 11, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Adidas (ADDYY - Free Report) , Coca-Cola (KO - Free Report) , Visa (V - Free Report) , Budweiser (BUD - Free Report) and McDonald’s (MCD - Free Report) .
RYAM KBH HSC ADDYY WLK ALSN LB RYAM.PRA MCHP TRTN BGSF V MU SCVL CCK OXY MCD
2018-06-11 - Asif
Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...
2018-06-11 - Asif
Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...
2018-06-11 - Asif
Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...
Silicon Investor Message Boards
This table lists all message boards related to OXY / Occidental Petroleum Corp. on message board site Silicon Investor.
|OXY: Occidental Petroleum Corp||ProxyMed (PILL)|
|AOXY, diverse,undiscovered in the investment community||The Official SI Oxymoron Thread|
|Accel-KKR HEAR Proxy Fraud?||Online Trading - An Oxymoron? (EGRP, AMTD, NBD, DLJ, SCH)|
|McMoran Oil u0026 Gas (MOXY)|
as of ET